Literature DB >> 27708975

Janus kinase 2 V617F mutation and thrombotic events in Behcet's disease: The Alexandria experience.

Fahd Adeeb1, Manal Tayel2, Dalal M El Kaffash3, Khairunnisa Mohd Idris2, Muhammad Fikri Abu Hassan2, Alexander Duncan Fraser1.   

Abstract

Entities:  

Year:  2016        PMID： 27708975      PMCID： PMC5042234          DOI： 10.5152/eurjrheum.2015.0067

Source DB:  PubMed          Journal:  Eur J Rheumatol        ISSN： 2147-9720


× No keyword cloud information.
  5 in total

1.  JAK2 (V617F) mutation is not associated with thrombosis in Behcet syndrome.

Authors:  M Cem Ar; Gülen Hatemi; Seda Ekizoğlu; Hülya Bilgen; Sevgi Saçli; A Nur Buyru; Teoman Soysal; Birsen Ülkü; Hasan Yazici
Journal:  Clin Appl Thromb Hemost       Date:  2011-12-26       Impact factor: 2.389

2.  The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis.

Authors:  D Colaizzo; L Amitrano; G L Tiscia; G Scenna; E Grandone; M A Guardascione; V Brancaccio; M Margaglione
Journal:  J Thromb Haemost       Date:  2006-10-20       Impact factor: 5.824

Review 3.  JAK2V617F mutation in patients with thrombosis: to screen or not to screen?

Authors:  S G Xavier; T Gadelha; S M Rezende; I R Zalcberg; N Spector
Journal:  Int J Lab Hematol       Date:  2010-12-01       Impact factor: 2.877

4.  Amplification refractory mutation system, a highly sensitive and simple polymerase chain reaction assay, for the detection of JAK2 V617F mutation in chronic myeloproliferative disorders.

Authors:  Qiaofang Chen; Pin Lu; Amy V Jones; Nicholas C P Cross; Richard T Silver; Y Lynn Wang
Journal:  J Mol Diagn       Date:  2007-04       Impact factor: 5.568

Review 5.  JAK and STAT signaling molecules in immunoregulation and immune-mediated disease.

Authors:  John J O'Shea; Robert Plenge
Journal:  Immunity       Date:  2012-04-20       Impact factor: 31.745
  5 in total
  1 in total

1.  Trisomy 8-positive Polycythemia Vera Complicated with Intestinal Behçet's-like Disease: A New Perspective for a Clinical Approach.

Authors:  Yuki Mori; Fumihiko Iwamoto; Toru Kuno; Shoji Kobayashi; Takashi Yoshida; Tatsuya Yamaguchi; Shinichi Takano; Tetsuo Kondo; Keita Kirito; Nobuyuki Enomoto
Journal:  Intern Med       Date:  2021-11-06       Impact factor: 1.282
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.